摘要
HIV-1整合酶在反转录过程中催化病毒DNA插入人类细胞基因组。由于整合酶在人类细胞中缺乏同源物以及它在HIV-1复制中的重要作用,整合酶是一个有吸引力的治疗靶点。尽管HIV-1整合酶抑制剂的研究取得了重大进展,但一些棘手的问题,如耐药性,阻碍了HIV-1整合酶抑制剂的进一步研究。本文简要介绍了HIV-1整合酶的结构、功能和催化机制,并对近年来HIV-1整合酶小分子抑制剂的研究进展作出了不同的结论。
关键词: 艾滋病,整合酶,HIV-1整合酶抑制剂,抗艾滋病药物,双抑制剂,变构整合酶抑制剂。
Current Medicinal Chemistry
Title:Recent Advances in Small-Molecule HIV-1 Integrase Inhibitors
Volume: 28 Issue: 24
关键词: 艾滋病,整合酶,HIV-1整合酶抑制剂,抗艾滋病药物,双抑制剂,变构整合酶抑制剂。
摘要: HIV-1 integrase catalyzed the insertion of viral DNA into the genome of human cells in the process of retrotranscription. Integrase is an attractive target for HIV-1 treatment due to the lack of its homologue in human cells and its vital role in HIV-1 replication. Although major progress in the development of HIV-1 integrase inhibitors has been made, some thorny problems, such as drug resistance, led to the further study of HIV-1 integrase inhibitors. This review briefly discussed the structure, function, and mechanism of catalysis of HIV-1 integrase and made a different conclusion for recent advances in small-molecule inhibitors of HIV-1 integrase.
Export Options
About this article
Cite this article as:
Recent Advances in Small-Molecule HIV-1 Integrase Inhibitors, Current Medicinal Chemistry 2021; 28 (24) . https://dx.doi.org/10.2174/0929867328666210114124744
DOI https://dx.doi.org/10.2174/0929867328666210114124744 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insects Antiviral and Anticancer Peptides: New Leads for the Future?
Protein & Peptide Letters Autophagy Fails to Alter Withaferin A-Mediated Lethality in Human Breast Cancer Cells
Current Cancer Drug Targets Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update
Current Pharmaceutical Design Identification of Tyrosine Kinase Src Responsible for Antimicrobial Peptides Production in Bombyx mori
Protein & Peptide Letters Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Withdrawal Notice: Prognosis And Prediction Of Breast Cancer (Bc) Using Growing Mlt (Machine Learning Techniques)
Recent Advances in Computer Science and Communications New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2
Current Medicinal Chemistry - Anti-Cancer Agents Designing HIV Integrase Inhibitors-Shooting the Last Arrow
Current Medicinal Chemistry Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Current Medicinal Chemistry Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases
Current Cancer Drug Targets Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Unleashing the Potential of Microbial Natural Products in Drug Discovery: Focusing on <i>Streptomyces</i> as Antimicrobials Goldmine
Current Topics in Medicinal Chemistry Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments
Current Drug Targets Hierarchy of Knowledge Translation: From Health Problems to Ad-Hoc Drug Design
Current Medicinal Chemistry Promising Targets in Anti-cancer Drug Development: Recent Updates
Current Medicinal Chemistry Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design The Long and Winding Road to Cancer Treatment: The Trail System
Current Pharmaceutical Design Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases
Current Protein & Peptide Science Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research